8-[(6-Acetamidopyridin-3-yl)oxy]-4,5-dihydrothieno[3,4-g][1,2]benzisothiazole-6-carboxamide

ID: ALA4086487

PubChem CID: 126511999

Max Phase: Preclinical

Molecular Formula: C17H14N4O3S2

Molecular Weight: 386.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1

Standard InChI:  InChI=1S/C17H14N4O3S2/c1-8(22)21-12-5-3-10(7-19-12)24-17-13-11(15(25-17)16(18)23)4-2-9-6-20-26-14(9)13/h3,5-7H,2,4H2,1H3,(H2,18,23)(H,19,21,22)

Standard InChI Key:  BKXGAUBREGVJQM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    8.8381   -7.4755    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3796   -9.3423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0917   -9.7506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8037   -8.5173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8037   -9.3387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5850   -9.5926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0679   -8.9281    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.5850   -8.2635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6471   -7.3073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3796   -8.5173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0917   -8.1005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9154   -7.2945    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.0943   -7.2131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7632   -7.9688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8399  -10.3774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2878  -10.9905    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6469  -10.5490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1937   -7.9248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0020   -7.7571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2614   -6.9718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7065   -6.3539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9003   -6.5248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0690   -6.8027    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6192   -7.4176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4268   -7.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3618   -8.2015    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 10  2  1  0
  2  3  1  0
  3  5  1  0
  4 11  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  4  2  0
  8  1  1  0
  1  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  6 15  1  0
 15 16  2  0
 15 17  1  0
  9 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  9  1  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4086487

    ---

Associated Targets(Human)

CDK19 Tchem Cyclin-C/Cyclin-dependent kinase 19 (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK8 Tchem Cell division protein kinase 8 (1536 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK8 Tchem CDK8/Cyclin C (1054 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.46Molecular Weight (Monoisotopic): 386.0507AlogP: 3.21#Rotatable Bonds: 4
Polar Surface Area: 107.20Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.28CX Basic pKa: 3.32CX LogP: 2.19CX LogD: 2.19
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: -1.00

References

1. Ono K, Banno H, Okaniwa M, Hirayama T, Iwamura N, Hikichi Y, Murai S, Hasegawa M, Hasegawa Y, Yonemori K, Hata A, Aoyama K, Cary DR..  (2017)  Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivatives.,  25  (8): [PMID:28302507] [10.1016/j.bmc.2017.02.038]

Source